Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012)
Vertex Pharmaceuticals (VRTX) posted quarterly Change in Taxes of -$3.2 million for Q4 2012, down 236.03% year-over-year from $2.3 million in Q1 2012, and down 185.99% quarter-over-quarter from $3.7 million in Q3 2012.
Vertex Pharmaceuticals (VRTX) Change in Taxes (2011 - 2012) Analysis & Trends
Vertex Pharmaceuticals' Change in Taxes history runs 2 years deep, the most recent figure standing at -$3.2 million for Q4 2012.
- In Q4 2012, Change in Taxes fell 236.03% year-over-year to -$3.2 million; the TTM figure through Dec 2012 stood at -$11.4 million (changed N/A YoY), while the FY2012 annual figure was -$11.4 million, down 194.08% from the prior year.
- Change in Taxes for Q4 2012 stood at -$3.2 million, down from $3.7 million in the prior quarter.
- The five-year high for Change in Taxes was $3.7 million in Q3 2012, with the low at -$11.9 million in Q1 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Roivant Sciences | 26.20 Bn | 26.20 Bn | 1.16 Mn | -10.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | -3.16 Mn |
| Dec 31, 2012 | -3.16 Mn |
| Sep 30, 2012 | 3.67 Mn |
| Sep 30, 2012 | 3.67 Mn |
| Mar 31, 2012 | -11.87 Mn |
| Mar 31, 2012 | -11.87 Mn |
| Dec 31, 2011 | 2.32 Mn |
| Dec 31, 2011 | 2.32 Mn |
| Sep 30, 2011 | -5.46 Mn |
| Sep 30, 2011 | -5.46 Mn |